Table 8. Analysis of changes in CK2 gene expression in leukemia.

P-values, fold change, rank and datasets are shown. (* = childhood leukemia).

Gene	p-value	Fold Change	Rank (Top %)	Dataset	#Samples	Reference
Pro-B Acute Lymphoblastic Leukemia
CK2α’	9.25 10−25	1.515	3%	Haferlach Leukemia	2096	[104]
B-Cell Acute Lymphoblastic Leukemia (B-ALL)
CK2α	1.57 10−4	-1.63	5%	Maia Leukemia*	28	[85]
	0.001	-1.758	10%	Coustan-Smith Leukemia*	288	[86]
	0.004	1.528	35%	Andersson Leukemia*	127	[87]
CK2α’	4.54 10−26	1.421	5%	Haferlach Leukemia	2096	[104]
	8.31 10−29	1.389	6%	Haferlach Leukemia*	2096	[104]
	2.65 10−7	2.189	10%	Andersson Leukemia*	127	[87]
CK2β	6.45 10−15	2.130	2%	Andersson Leukemia*	127	[87]
CK2αP	0.004	1.528	35%	Andersson Leukemia*	127	[87]
T-Cell Acute Lymphoblastic Leukemia (T-ALL)
CK2α	4.04 10−4	1.743	20%	Andersson Leukemia*	127	[87]
	0.004	-1.399	14%	Coustan-Smith Leukemia*	288	[86]
CK2α’	1.77 10−7	2.496	4%	Andersson Leukemia*	127	[87]
	1.35 10−27	1.576	5%	Haferlach Leukemia	2096	[104]
CK2β	1.44 10−8	2.654	2%	Andersson Leukemia*	127	[87]
CK2αP	0.011	1.589	33%	Andersson Leukemia*	127	[87]
Acute Myeloid Leukemia (AML)
CK2α	0.002	1.609	27%	Andersson Leukemia*	127	[87]
CK2α’	1.47 10−7	2.030	5%	Andersson Leukemia*	127	[87]
	1.05 10−20	1.417	5%	Haferlach Leukemia*	2096	[104]
CK2β	3.26 10−8	2.006	4%	Andersson Leukemia*	127	[87]
	2.96 10−4	-1.928	5%	Stegmaier Leukemia*	87	[91]
CK2αP	0.002	1.609	27%	Andersson Leukemia*	127	[87]
Chronic Lymphocytic Leukemia (CLL)
CK2α	1.34 10−6	-2.228	5%	Rosenwald Multi-cancer	102	[105]
	5.89 10−34	-1.453	7%	Haferlach Leukemia	2096	[104]
	2.06 10−4	-1.505	10%	Alizadeh Leukemia	120	[97]
CK2α’	3.13 10−34	1.455	8%	Haferlach Leukemia	2096	[104]
	3.82 10−4	-1.316	19%	Rosenwald Multi-cancer	102	[105]
CK2β	3.33 10−4	1.885	10%	Haslinger Leukemia	111	[98]
	2.81 10−6	-1.391	8%	Basso Lymphoma	336	[100]
	0.004	-1.381	8%	Rosenwald Lymphoma	293	[101]
Hairy Cell Leukemia (HCL)
CK2α	2.48 10−4	-1.308	16%	Basso Lymphoma	336	[100]
CK2α’	1.42 10−8	-1.876	3%	Basso Lymphoma	336	[100]